DEF: Movano Seeks Shareholder Nod for $1B Equity Facility, Share Increase
Proxy Statement
Movano Inc. calls a special meeting to approve a $1 billion equity facility, a five-fold increase in authorized shares, and expanded stock options for employees and directors amid financial constraints.
Summary
- Movano Inc. is holding a special meeting on December 16, 2025, to vote on four key proposals.
- Shareholders will vote on approving the issuance of over 20% of common stock under a ChEF Purchase Agreement with Chardan Capital Markets LLC, allowing the company to raise up to $1,000,000,000 over 36 months.
- The company seeks to amend its Certificate of Incorporation to increase authorized common stock from 500,000,000 to 2,500,000,000 shares.
- An amendment to the 2019 Omnibus Incentive Plan is proposed to increase shares reserved for issuance by 500,000 shares, bringing the total to 656,000 shares.
- This increase in the incentive plan is partly due to employees and directors accepting discounted stock options in lieu of cash compensation from May 2025 through Q4 2025, citing "very limited resources and inability to raise capital."
- Contingent discounted stock options were granted on November 5, 2025, with an exercise price of $1.25, exercisable only upon shareholder approval of the Incentive Plan Proposal.
- The company also seeks approval to adjourn the meeting if needed to secure sufficient votes.
- As of November 10, 2025, there were 834,857 shares of common stock and 3,000 shares of Series A Preferred Stock (convertible into 87,694 common shares) outstanding.
Sentiment
Score: 3
Explanation: The filing reveals significant financial distress, with the company having 'very limited resources and inability to raise capital,' leading to employees and directors accepting equity in lieu of cash. While the proposed capital raise and share increase offer potential solutions, they come with substantial dilution risks for existing shareholders and indicate a challenging operational environment. The urgency of these proposals, tied to a merger, suggests a critical juncture for the company.
Positives
- The ChEF Purchase Agreement provides a potential source of capital up to $1,000,000,000, offering financial flexibility.
- Increasing authorized shares provides flexibility for future financings, strategic acquisitions, and equity compensation without immediate further shareholder approval.
- The expansion of the incentive plan allows the company to continue attracting and retaining talent through equity compensation, especially after employees and directors accepted discounted options in lieu of cash.
- The company is actively pursuing a merger with Corvex, Inc., indicating strategic growth initiatives.
Negatives
- The issuance of shares under the ChEF Purchase Agreement will have a dilutive effect on existing stockholders' voting power, economic rights, liquidation value, book/market value, and future earnings.
- The potential for significant future dilution exists if the proposed increase in authorized shares from 500,000,000 to 2,500,000,000 is fully utilized.
- The company's "very limited resources and inability to raise capital" led to employees and directors accepting discounted stock options in lieu of cash compensation, indicating financial distress.
- Sales under the ChEF facility will occur at a discount to the Volume Weighted Average Price (VWAP) of the common stock (ranging from 2.5% to 10% depending on public float and purchase type).
- The issuance and sale of shares could cause the market price of common stock to decline or result in greater price volatility.
Risks
- Failure to approve the ChEF Share Issuance Proposal would restrict the company from issuing shares in excess of 166,887 at a price less than $5.30, limiting capital raising flexibility.
- Non-approval of the COI Amendment Proposal would limit strategic flexibility for future financings, acquisitions, and equity compensation.
- Non-approval of the Incentive Plan Proposal would prevent the exercisability of discounted stock options granted to employees and directors, potentially impacting morale and retention.
- The Board reserves the right to abandon the COI Amendment even if approved by stockholders, creating uncertainty.
- The ChEF Purchase Agreement includes legal fees and disbursements reimbursable to Chardan, adding to company expenses.
- The company's common stock could be delisted if it fails to be listed or quoted on Nasdaq or a successor Principal Market, which would terminate the ChEF Purchase Agreement.
Future Outlook
The company aims to secure significant capital raising flexibility through a committed equity facility and a substantial increase in authorized shares to support future financings, strategic acquisitions, and general corporate purposes. These actions are critical for the company's ongoing operations and its planned merger with Corvex, Inc., especially given its current limited resources.
Management Comments
- "You are cordially invited to attend the special meeting of stockholders of Movano Inc. to be held at 1:00 p.m., Pacific Time, on December 16, 2025." John Mastrototaro, CEO.
- "The virtual meeting technology we employ provides expanded access, improved communication and cost savings for our stockholders." John Mastrototaro, CEO.
- "Our Board has determined that the Purchase Agreement with Chardan is in the best interests of the Company and our stockholders because the continuous right to require Chardan to purchase our shares at a market-based price provides us with a potential source of capital and the ability to access that capital when and as needed."
- "The Board believes that additional authorized shares of common stock will enable us to take timely advantage of market conditions and financing opportunities that become available to us."
- "The Board believes that the proposed increase in authorized common stock... is in the best interests of the Company and its stockholders and will better position the Company to pursue its business objectives, attract strategic capital, and respond to market opportunities in a timely and efficient manner."
- "Our Board has determined that additional shares will be required to meet the Company equity compensation requirements on a going forward basis."
- "Beginning in May 2025, due to the Company’s very limited resources and inability to raise capital, Company employees and members of the Board agreed to accept restricted stock units (RSUs) in lieu of cash compensation."
- "In recognition of extraordinary efforts that resulted in the Company’s entry into the Agreement and Plan of Merger with Corvex, Inc. announced by the Company on November 10, 2025, the Board approved the grant of additional one-time discounted stock options to employees and members of the Board."
Industry Context
The company's pursuit of a significant equity facility and a substantial increase in authorized shares, coupled with the need for employees and directors to accept equity in lieu of cash, suggests a challenging financial environment. This strategy is common for early-stage or financially constrained companies in the technology or healthcare sectors (given Movano's focus on health tech, though not explicitly stated in this filing) that require substantial capital for R&D, market penetration, or strategic M&A, but face difficulties securing traditional financing. The planned merger with Corvex, Inc. indicates a strategic move to consolidate or expand operations, potentially seeking synergies or a stronger market position.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Increase the number of authorized shares of common stock from 500,000,000 to 2,500,000,000 shares, and correspondingly increase the total number of authorized shares of all capital stock. | Upon filing with Delaware Secretary of State, if approved by stockholders and not abandoned by Board. | Provides greater flexibility for future capital raises, acquisitions, and equity compensation, but also enables significant potential dilution of existing shareholders' equity and voting rights. |
| Amendment to 2019 Omnibus Incentive Plan | Increase the number of shares reserved for issuance under the plan by 500,000 shares, bringing the total to 656,000 shares. | November 10, 2025, subject to stockholder approval. | Allows the company to continue using equity for compensation, crucial for retaining and incentivizing employees and directors, especially given past cash constraints. However, it contributes to overall share dilution. |
Stakeholder Impact
- Shareholders: Significant potential for dilution of voting power, economic rights, liquidation value, book and market value, and future earnings due to the ChEF share issuance and the large increase in authorized shares. The stock price could also decline or become more volatile.
- Employees and Directors: Will benefit from the increased shares available under the incentive plan, allowing for continued equity compensation, especially after accepting discounted options in lieu of cash. This helps retain key personnel.
- Chardan Capital Markets LLC: Will act as the purchaser in the committed equity facility, earning discounts on share purchases and reimbursement for legal fees.
- Corvex, Inc.: The merger partner, whose consent is required for the use of ChEF proceeds prior to closing, indicating a strong influence on Movano's financial strategy.
Next Steps
- Hold a Special Meeting of stockholders on December 16, 2025, to vote on the proposed amendments.
- If approved, file the Certificate of Amendment with the Secretary of State of Delaware to increase authorized shares.
- If approved, the company will have the right, but not the obligation, to sell shares to Chardan under the ChEF Purchase Agreement over a 36-month period.
- File a Current Report on Form 8-K with the SEC within four business days following the Special Meeting to announce voting results.
- Expect to hold a separate special meeting of stockholders to obtain approvals necessary to complete the Merger with Corvex, Inc. and related matters.
Key Dates
| Date | Description |
|---|---|
| November 1, 2024 | Initial grant of RSUs for Board members covered this period to June 30, 2025. |
| December 31, 2024 | Date for equity compensation plan information and outstanding equity awards. |
| May 2025 | Beginning of period when employees and Board members accepted RSUs in lieu of cash compensation due to limited resources. |
| November 5, 2025 | Date when no shares remained available for issuance under the 2019 Incentive Plan. Also, date contingent discounted stock options were granted to employees and directors. |
| November 6, 2025 | Date of entry into ChEF Purchase Agreement and ChEF Registration Rights Agreement with Chardan Capital Markets LLC. Also, date of entry into Agreement and Plan of Merger with Corvex, Inc. |
| November 10, 2025 | Record date for determining stockholders entitled to notice of and to vote at the Special Meeting. Also, date Board approved and adopted Amendment No. 3 of the 2019 Incentive Plan. |
| November 15, 2025 | Date for beneficial ownership reporting. |
| November 24, 2025 | Date of mailing paper copies of Proxy Statement and proxy card to stockholders of record and providing access to materials online. |
| December 15, 2025 | Telephone and Internet voting facilities for stockholders of record close at 11:59 p.m., Eastern Time. |
| December 16, 2025 | Date of the Special Meeting of stockholders at 1:00 p.m. Pacific Time. |
| December 31, 2025 | Expiration date for contingent stock options granted on November 5, 2025. |
| December 16, 2026 | Webcast replay of the Special Meeting will be available until this date. |
| March 25, 2031 | Scheduled termination date for authority to make grants under the 2019 Incentive Plan. |
Recommendation
sellThe filing reveals a company in significant financial distress, explicitly stating 'very limited resources and inability to raise capital.' This led to employees and directors accepting discounted equity in lieu of cash. The proposals, while necessary for survival and strategic flexibility, involve substantial dilution risks for existing shareholders. The $1 billion equity facility, coupled with a five-fold increase in authorized shares, signals a high likelihood of future share issuances that will significantly dilute current holdings. The discounted nature of the equity facility and the low exercise price of contingent options ($1.25) further underscore the company's precarious position and the potential for downward pressure on the stock price. A seasoned investor would likely view these as strong indicators of fundamental weakness and significant downside risk, warranting a 'sell' recommendation.
Keywords
Movano Inc., MOVE, SEC Filing, Proxy Statement, DEF 14A, Capital Raise, Equity Facility, Chardan Capital Markets, Share Dilution, Authorized Shares, Stock Options, Incentive Plan, Corporate Governance, Nasdaq Listing Rules, Merger, Corvex Inc., Financial Flexibility
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.